| 1A03490 | Active | (1S,2R)-Eliglustat Diastereomer (25 mg) (N-[(1S,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A03030 | Active | (3R,4R)-Paroxol (25 mg) (((3R,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03020 | Active | (3S,4S)-Paroxol (25 mg) (((3S, 4S)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02040 | Active | (4-Methylbenzoyl)trifluoroacetone (25 mg) (1,1,1-Trifluoro-4-hydroxy-4-(4-methylphenyl)-3-buten-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A01970 | Active | (R)-Amlodipine (25 mg) (3-ethyl 5-methyl (R)-2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A00550 | Active | (R)-Clopidogrel Carboxylic Acid (10 mg) ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A02700 | Active | (R)-Laudanosine (25 mg) ((R)-1-(3,4-Dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Muscle Relaxants | Enquire
|
| 1A02860 | Active | (R)-N-Methyllaudanosine Iodide (25 mg) ((R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium, iodide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Muscle Relaxants | Enquire
|
| 1A03220 | Active | (S)-2-Amino-4-morpholinobutanoic acid hydrochloride (25 mg) ((S)-2-amino-4-morpholinobutanoic acid, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A01540 | Active | (S)-Glycidyl Phthalimide (25 mg) ((S)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A02630 | Active | (S)-Sitagliptin Phosphate (25 mg) ((S)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A01030 | Active | 1,2-Dihydro Fluticasone Propionate (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A04670 | Active | 1,3-Dimethyl-6-nitroindazole (25 mg) (1,3-dimethyl-6-nitro-1H-indazole) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A02590 | Active | 1,4-Bis(4-(2,3-dichlorophenyl)piperazin-1-yl)butane dihydrochloride (25 mg) (1,4-bis(4-(2,3-dichlorophenyl)piperazin-1-yl)butane, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A04080 | Active | 1-(2-Methoxyphenyl)-4-nitrosopiperazine Solution (1 mL (1 mg/mL)) (1-(2-Methoxyphenyl)-4-nitrosopiperazine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04420 | Active | 1-Benzhydryl-4-nitrosopiperazine (10 mg) (1-Benzhydryl-4-nitrosopiperazine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04130 | Active | 1-Benzhydryl-4-nitrosopiperazine Solution (1 mL (1 mg/mL)) (1-benzhydryl-4-nitrosopiperazine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04190 | Active | 1-Cyclopentyl-4-nitrosopiperazine (CPNP) Solution (1 mL (1 mg/mL)) (1-Cyclopentyl-4-nitrosopiperazine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04540 | Active | 1-Methoxy Empagliflozin (25 mg) ((2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A04020 | Active | 1-Methyl-4-nitrosopiperazine (MNP) Solution (1 mL (1 mg/mL)) (1-Methyl-4-nitrosopiperazine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A02920 | Active | 1-Oxo Ivabradine Hydrochloride (25 mg) ((S)-3-(3-(((3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-4,5-dihydro-1H-benzo[d]azepine-1,2(3H)-dione, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01040 | Active | 11-Ketofluticasone Propionate (25 mg) ((6S,8S,9R,10S,13S,14S,16R,17R)-6,9-Difluoro-17-(((fluoromethyl)thio)carbonyl)-10,13,16-trimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01230 | Active | 16Alpha-Hydroxy Prednisolone-14-ene (25 mg) ((8R,9S,10R,11S,13S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01220 | Active | 16Alpha-Hydroxy Prednisolone-14-ene Acetate (25 mg) (2-Oxo-2-((8R,9S,10R,11S,13S,16R,17S)-11,16,17-trihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)ethyl acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01260 | Active | 16Alpha-Hydroxy Prednisolone-9(11)-ene (25 mg) ((8S,10S,13S,14S,16R,17S)-16,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,10,12,13,14,15,16,17-decahydro-3Hcyclopenta[a]phenanthren-3-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01270 | Active | 16Alpha-Hydroxy Prednisolone-9(11)-ene Acetate (25 mg) (2-((8S,10S,13S,14S,16R,17S)-16,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01280 | Active | 16Alpha-Hydroxy Prednisolone-9(11)-ene Diacetate (25 mg) (2-((8S,10S,13S,14S,16R,17S)-16-acetoxy-17-hydroxy-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01250 | Active | 16Alpha-Hydroxy-11-keto Prednisolone (25 mg) (8S,9S,10R,13S,14S,16R,17S)-16,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthrene-3,11(6H)-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01240 | Active | 16Alpha-Hydroxy-11-keto Prednisolone Acetate (25 mg) (2-((8S,9S,10R,13S,14S,16R,17S)-16,17-dihydroxy-10,13-dimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A00880 | Active | 16alpha-Hydroxyprednisolone (25 mg) ((8S,9S,10R,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A00470 | Active | 17-Oxo Dexamethasone (10 mg) ((8S,9R,10S,11S,13S,14S,16R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A02010 | Active | 17alpha-Hydroxy13(17)a-homoprednisolone (25 mg) ((2R,3R,4aS,4bS,10aR,10bS,11S,12aS)-2,3,11-trihydroxy-2-(hydroxymethyl)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydrochrysene-1,8(2H,4bH)-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A05720 | Active | 2'-Carbamoyl Azilsartan (25 mg) (1-((2'-carbamoyl-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A05730 | Active | 2'-Carboxy Azilsartan Methyl Ester (25 mg) (4'-((2-ethoxy-7-(methoxycarbonyl)-1H-benzo[d]imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A05740 | Active | 2'-[Hydroxybiphenyl]-3-carboxylic acid (25 mg) (2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01340 | Active | 2,3-Dimethyl-2,3-butanediamine Dihydrochloride (25 mg) (2,3-dimethylbutane-2,3-diamine, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A02780 | Active | 2,4,5-Trimethylketoprofen (25 mg) (COLD SHIPMENT REQUIRED) ((2RS)-2-[3-(2,4,5-Trimethylbenzoyl)phenyl]propanoic Acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A03830 | Active | 2,4-Dichloro Vilanterol Trifenatate Isomer (25 mg) ((R)-4-(2-((6-(2-((2,4-dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol, triphenylacetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A02830 | Active | 2,4-Difluoro Sitagliptin (25 mg) ((3R)-3-Amino-4-(2,4-difluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]butan-1-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A03840 | Active | 2,5-Dichloro Vilanterol Trifenatate Isomer (25 mg) ((R)-4-(2-((6-(2-((2,5-dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol, 2,2,2-triphenylacetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A02820 | Active | 2,5-Difluoro Sitagliptin (25 mg) ((3R)-3-Amino-4-(2,5-difluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]butan-1-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A02750 | Active | 2-(3-Carboxyphenyl)propionitrile (25 mg) (2-(3-Carboxyphenyl)propionitrile) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A04440 | Active | 2-(4-Nitrosopiperazin-1-yl)pyrimidine (10 mg) (2-(4-nitrosopiperazin-1-yl)pyrimidine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04170 | Active | 2-(4-Nitrosopiperazin-1-yl)pyrimidine Solution (1 mL (1 mg/mL)) (2-(4-nitrosopiperazin-1-yl)pyrimidine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04970 | Active | 2-(5-Iodo-2-methylbenzyl)-5-phenylthiophene (COLD SHIPMENT REQUIRED) (25 mg) (2-(5-iodo-2-methylbenzyl)-5-phenylthiophene) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A04850 | Active | 2-(Chloromethyl)-4-methylquinazoline (25 mg) (Quinazoline, 2-(chloromethyl)-4-methyl) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A02450 | Active | 2-Dechloro Aripiprazole (25 mg) (7-(4-(4-(3-chlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02440 | Active | 2-Monobromo Aripiprazole Hydrochloride (25 mg) (7-(4-(4-(2-bromophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00560 | Active | 2-Oxo Clopidogrel (Mixture of Diastereomers) (10 mg) (methyl 2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A00570 | Active | 2-Oxo R-Clopidogrel (10 mg) (methyl (2R)-2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03210 | Active | 2-{4-[(methylamino)methyl]thiazol-2-yl}propan-2-ol hydrochloride (25 mg) (2-(4-((methylamino)methyl)thiazol-2-yl)propan-2-ol, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A02730 | Active | 21-Desacetyl Deflazacort (25 mg) ((11Beta,16Beta)-11,21-Dihydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A00210 | Active | 3'-(N,N-Didemethyl)-3'-N-formylazithromycin (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00070 | Active | 3'-(N,N-Didemethyl)azithromycin; (Aminoazithromycin) (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00080 | Active | 3'-De(dimethylamino)-3'-oxoazithromycin (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00840 | Active | 3'-Demethyl-3'-N-[(4-methylphenyl)sulfonyl]azithromycin (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A04490 | Active | 3-Acetamidophthalic acid (25 mg) (3-acetamidophthalic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Immunosuppresants | Enquire
|
| 1A04680 | Active | 3-Amino-4-tolylsulfonamide (25 mg) (3-amino-4-methylbenzenesulfonamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A02760 | Active | 3-Carboxyphenylacetonitrile (25 mg) (3-(Cyanomethyl)benzoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A03300 | Active | 3-Chloropropiophenone (25 mg) (1-Phenyl-3-chloro-1-propanone) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02570 | Active | 3-Dechloro Aripiprazole (25 mg) (7-(4-(4-(2-chlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03530 | Active | 3-Deoxy 3-Chloroabiraterone (25 mg) (3Beta-Chloro-17-(pyridin-3-yl)androsta-5,16-diene) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A03520 | Active | 3-Deoxy-3-acetyl Abiraterone-3-ene (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A02930 | Active | 3-Desmethyl Ivabradine Hydrochloride (25 mg) (1,3,4,5-tetrahydro-3-[3-[[[(7S)-3-hydroxy-4-methoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-7,8-dimethoxy-2H-3-benzazepin-2-one, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01650 | Active | 3-Hydroxy Desloratadine (25 mg) (8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-3-ol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihistamines | Enquire
|
| 1A04330 | Active | 3-Methyl Formoterol (50 mg) (N-(2-hydroxy-5-(1-hydroxy-2-((1-(4-methoxy-3-methylphenyl)propan-2-yl)amino)ethyl)phenyl)formamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A04880 | Active | 3-Methyl-7-(2-butyn-1-yl)-8-bromoxanthine (25 mg) (8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A02030 | Active | 4'-Hydroxycelecoxib (25 mg) (4-(5-(4-(hydroxymethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A04370 | Active | 4-(N-Methyl-N-nitrosamino)-1-(pyridin-3-yl)-1-butanone (NNK) (10 mg) (N-methyl-N-(4-oxo-4-(pyridin-3-yl)butyl)nitrous amide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04010 | Active | 4-(N-Methyl-N-nitrosamino)-1-(pyridin-3-yl)-1-butanone (NNK) Solution (1 mL (1 mg/mL)) (N-methyl-N-(4-oxo-4-(pyridin-3-yl)butyl)nitrous amide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A05830 | Active | 4-Chloro-3-(trifluoromethyl)aniline (COLD SHIPMENT REQUIRED) (25 mg) (5-Amino-2-chlorobenzotrifluoride;4-Chloro-3-(trifluoromethyl)aniline) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A02950 | Active | 4-Desmethyl Ivabradine Hydrochloride (25 mg) ((S)-3-(3-(((4-hydroxy-3-methoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A00580 | Active | 4-Fluoro Risperidone (COLD SHIPMENT REQUIRED) (10 mg) (3-(2-(4-(4-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02160 | Active | 4-Hydroxy Duloxetine Acetate (25 mg) ((S)-4-(3-(methylamino)-1-(thiophen-2-yl)propoxy)naphthalen-1-ol, acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00900 | Active | 4-Methylacetophenone (1-(4-Methylphenyl)-1-ethanone (4'-Methylacetophenone)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A04140 | Active | 4-Nitroso-1-(4-fluorobenzoyl)piperazine Solution (1 mL (1 mg/mL)) ((4-fluorophenyl)(4-nitrosopiperazin-1-yl)methanone) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04410 | Active | 4-Nitrosopiperazine-1-ethanol (10 mg) (2-(4-Nitrosopiperazin-1-yl)ethan-1-ol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04100 | Active | 4-Nitrosopiperazine-1-ethanol Solution (1 mL (1 mg/mL)) (2-(4-Nitrosopiperazin-1-yl)ethan-1-ol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04820 | Active | 4-Phenylbutyl(benzyl)amine hydrochloride (25 mg) (N-benzyl-4-phenylbutan-1-amine, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A02490 | Active | 5-(4-Bromobutoxy)-3,4-dihydroquinolin-2(1H)-one (25 mg) (5-(4-bromobutoxy)-3,4-dihydroquinolin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03590 | Active | 5-Chloro Hydrochlorothiazide (25 mg) (5,6-dichloro-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Others-Chemical Medicines | Enquire
|
| 1A01770 | Active | 5-Dimethylaminobutyryl Citalopram Oxalate (25 mg) (4-(dimethylamino)-1-(1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-yl)butan-1-one, oxalate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00520 | Active | 5-Fluoro Risperidone (25 mg) (3-(2-(4-(5-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03200 | Active | 5-Hydroxy Ivabradine (25 mg) (3-(3-((((S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-5-hydroxy-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03380 | Active | 5-Hydroxy Lenalidomide (25 mg) (3-(4-amino-5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A04300 | Active | 6-Bromo-6-deoxy-gamma-cyclodextrin (10 mg) (octakis-(6-bromo-6-deoxy)-gamma-cyclodextrin) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Others-Chemical Medicines | Enquire
|
| 1A03580 | Active | 6-Keto Fulvestrant (25 mg) ((7Alpha,17Beta)-7-[9-[4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-3,17Beta-dihydroxyestra-1,3,5(10)-trien-6-one; 7Alpha-{9-[(4,4,5,5,5,-Pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-6-one-3,17Beta-diol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A01050 | Active | 6-Methyl-4-phenylchromanol (25 mg) (6-Methyl-4-phenylchroman-2-ol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Renal | Enquire
|
| 1A01060 | Active | 6-Methyl-4-phenylchromanone (25 mg) (6-Methyl-4-phenylchroman-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Renal | Enquire
|
| 1A04260 | Active | 6-O-Methylerythromycin A 9-(O-methyloxime) (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A06070 | Active | 6-Oxo Boldione | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A00110 | Active | 6Beta-Hydroxy Ethinyl Estradiol (25 mg) ((6R,8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,6,17-triol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01400 | Active | 6Beta-Hydroxybudesonide (25 mg) ((2R,6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-2,7-dihydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A00100 | Active | 6alpha-HYDROXY ETHINYL ESTRADIOL (COLD SHIPMENT REQUIRED) (25 mg) (19-Nor-17alpha-pregna-1,3,5(10)-trien-20-yne-3,6alpha,17-triol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01390 | Active | 6alpha-Hydroxybudesonide (25 mg) ((2S,6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-2,7-Dihydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A04920 | Active | 7-Chloromethyl 17-Epidrospirenone (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A05070 | Active | 7-Chloromethyl Drospirenone (10 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A02070 | Active | 7-Dehydrocholesterol (25 mg) (COLD SHIPMENT REQUIRED) ((3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A02970 | Active | 7-Desmethyl Ivabradine (25 mg) ((S)-3-(3-(((3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)(methyl)amino)propyl)-7-hydroxy-8-methoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A00590 | Active | 7-Fluoro Risperidone (COLD SHIPMENT REQUIRED) (10 mg) (3-(2-(4-(7-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A04900 | Active | 7-Hydroxymethyl Drospirenone (10 mg) (7Beta-(Hydroxymethyl)-3-oxo-15alpha,16alpha-dihydro-3'H-cyclopropa[15,16]-17alpha-pregn-4-ene-21,17-carbolactone) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A03510 | Active | 7-Keto abiraterone Acetate (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A04340 | Active | 8-Desmethyl Ivabradine Hydrochloride (25 mg) ((S)-3-(3-(((3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)(methyl)amino)propyl)-8-hydroxy-7-methoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A02510 | Active | 8-Hydroxy-3,4-dihydroquinolin-2(1H)-one (25 mg) (3,4-dihydro-8-hydroxy-2(1H)-Quinolinone) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02020 | Active | 9-Bromo-16alpha-hydroxyprednisolone (25 mg) ((8S,9R,10S,11S,13S,14S,16R,17S)-9-bromo-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A03440 | Active | Abiraterone Ethyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-ethoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A03450 | Active | Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A06460 | Active | Acetyl Rotigotine Hydrochloride | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01070 | Active | Alpha-Naphthol (25 mg) (naphthalen-1-ol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01610 | Active | Aminophenylmorpholin-2-one (25 mg) (4-(4-aminophenyl)morpholin-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01530 | Active | Aminophenylmorpholinone (25 mg) (4-(4-aminophenyl)morpholin-3-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A00200 | Active | Amlodipine Ethyl Analog (25 mg) (diethyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate, maleate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A00030 | Active | Amlodipine Methyl Analog (25 mg) (dimethyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate, maleate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A00490 | Active | Amoxicilloic Acid Dimers 1 and 2 (10 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00330 | Active | Amoxicilloic amoxilloic acid dimers 1, 2, 3, and 4 (5 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A07110 | Active | Anastrozole Diacid | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A03430 | Active | Anhydro Abiraterone (25 mg) (3-((8R,9S,10R,13S,14S)-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 17-(Pyridin-3-yl)androsta-3,5,16-triene) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A03650 | Active | Anhydroclarithromycin (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A07120 | Active | Apixaban Open Ring Amide | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A04480 | Active | Apremilast Desphthalyl Amine (25 mg) ((S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethan-1-amine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Immunosuppresants | Enquire
|
| 1A04460 | Active | Apremilast Open Ring 3-acetamide (25 mg) ((S)-3-acetamido-2-((1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)carbamoyl)benzoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Immunosuppresants | Enquire
|
| 1A02460 | Active | Aripiprazole 4,4'-dimer (25 mg) (7,7'-((((ethane-1,1-diylbis(2,3-dichloro-4,1-phenylene))bis(piperazine-4,1-diyl))bis(butane-4,1-diyl))bis(oxy))bis(3,4-dihydroquinolin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02470 | Active | Aripiprazole Acid Analog (25 mg) (4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butanoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02480 | Active | Aripiprazole Bromobutoxyquinolinone Analog (25 mg) (7-(4-bromobutoxy)quinolin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02420 | Active | Aripiprazole Diquinolinone Butanediol (25 mg) (7,7'-(butane-1,4-diylbis(oxy))bis(3,4-dihydroquinolin-2(1H)-one)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02550 | Active | Aripiprazole Hydroxydihydroquinolinone Analog (25 mg) (7-hydroxy-3,4-dihydroquinolin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02560 | Active | Aripiprazole Hydroxyquinolinone Analog (25 mg) (7-hydroxyquinolin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02530 | Active | Aripiprazole Isomer (25 mg) (5-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02520 | Active | Aripiprazole N-oxide Isomer (25 mg) (4-(2,3-dichlorophenyl)-1-(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butyl)piperazine 4-oxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02540 | Active | Aripiprazole Spiro Analog (25 mg) (8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium, bromide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02410 | Active | Aripiprazole di(quinolinonylbutyl) ether analog (25 mg) (7,7'-((oxybis(butane-4,1-diyl))bis(oxy))bis(3,4-dihydroquinolin-2(1H)-one)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A06190 | Active | Atazanavir Ethyl Analog | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A06150 | Active | Atazanavir S,R,S,S-diastereomer | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A00760 | Active | Atorvastatin 3-deoxyhept-2-enoic Acid (25 mg) ((S,E)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxyhept-2-enoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A00790 | Active | Atorvastatin Calcium Epoxy Pyrrolooxazin 7-Hydroxy Analog (25 mg) (Calcium 4-(1b-(4-fluorophenyl)-7-hydroxy-7-isopropyl-1a-phenyl-7a-(phenylcarbamoyl)hexahydro-3H-oxireno[2',3':3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3-hydroxybutanoate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A00800 | Active | Atorvastatin Epoxy Tetrahydrofuran Analog (25 mg) (COLD SHIPMENT REQUIRED) (4-(4-Fluorophenyl)-2,4-dihydroxy-2-(1-methylethyl)-N,5-diphenyl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A00010 | Active | Atorvastatin Ethyl Ester (25 mg) (ethyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A00020 | Active | Atorvastatin Methyl Ester (25 mg) (methyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A00820 | Active | Atorvastatin Pyrrolidone Lactone (25 mg) (5-(4-Fluorophenyl)-1-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3-isopropyl-2-oxo-N,4-diphenyl-2,3-dihydro-1H-pyrrole-3-carboxamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A00810 | Active | Atorvastatin Sodium Pyrrolidone Analog (25 mg) ((3R,5R)-5-(4-Fluorophenyl)-2,3-dihydro-3,5-dihydroxy-3-(1-methylethyl)-2-oxo-4-phenyl-3-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Sodium Salt) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A00830 | Active | Atorvastatin tert-Butyl Ester (25 mg) (tert-butyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A02880 | Active | Atracurium Iodide Quaternary Alcohol Acetate (25 mg) ((1R)-2-(3-((5-acetoxypentyl)oxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium, iodide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Muscle Relaxants | Enquire
|
| 1A00260 | Active | Azacitidine Formyl Amidine Analog (25 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) (N-(Formyl amidino)-N'-Beta-D-ribofuranosylurea) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A00270 | Active | Azacitidine Isomer -3 (25 mg) (1-Beta-D-Ribofuranosyl-3-aminocarbonyl guanidine acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A00850 | Active | Azithromycin B (3-deoxyazithromycin) (25 mg) (COLD SHIPMENT REQUIRED) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00860 | Active | Azithromycin C (3''-O-demethylazithromycin) (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A02910 | Active | Benzoylphenylacetonitrile (25 mg) (3-Benzoylbenzeneacetonitrile) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00540 | Active | Bis((R)-butyramide) (10 mg) ((R)-2-amino-N-((R)-1-amino-1-oxobutan-2-yl)butanamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01350 | Active | Bis(2-methylaminoethyl) Ether (25 mg) (2,2'-oxybis(N,N-dimethylethan-1-amine)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A01330 | Active | Bis(2-methylaminoethyl) Ether Hydrochloride (25 mg) (2,2'-oxybis(N-methylethan-1-amine), hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00150 | Active | Bis(dibenzothiazepinyl) Piperazine (25 mg) (1,4-Bis(dibenzo[b,f][1,4]thiazepin-11-yl)piperazine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01300 | Active | Bis(dimethylaminoethyl) Ether Dihydrochloride (25 mg) (2,2'-oxybis(N,N-dimethylethan-1-amine), hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A03770 | Active | Bortezomib Acid Analog (25 mg) ((2S)-3-Phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoic Acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A03780 | Active | Bortezomib Amide Analog (25 mg) (N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A03400 | Active | Bortezomib L-phenylalanyl analog (COLD SHIPMENT REQUIRED) (25 mg) (((R)-3-methyl-1-((S)-3-phenyl-2-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)propanamido)butyl)boronic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Others-Chemical Medicines | Enquire
|
| 1A03480 | Active | Bosentan Bis4(tert-butylbenzenesulfonamide) (25 mg) (N,N'-(5-(2-methoxyphenoxy)-[2,2'-bipyrimidine]-4,6-diyl)bis(4-(tert-butyl)benzenesulfonamide)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A04590 | Active | Brexpiprazole N-oxide (25 mg) (4-(benzo[b]thiophen-4-yl)-1-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazine 1-oxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00690 | Active | Bromobudesonide (25 mg) ((6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-6b-bromo-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12, 12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01370 | Active | Budesonide 21-butyrate (25 mg) (2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-10-propyl-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl butyrate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A00680 | Active | Budesonide 9(11)-ene (25 mg) ((6aS,8aS,8bS,11aR,12aS,12bS)-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,8,8a,8b,11a,12,12a,12b-decahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A00510 | Active | Budesonide Acetaldehyde Acetal (25 mg) (16alpha,17-[(1RS)-ethylidenebis(oxy)]-11beta,21-dihydroxypregna-1,4-diene-3,20-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A00500 | Active | Budesonide D-homo Analog (10 mg) ((4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-4b,6,6a,7a,10a,11,11a,11b,12,13-decahydrochryseno[2,3-d][1,3]dioxole-2,7(4aH,5H)-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A02000 | Active | Budesonide Pyruvic Acid (25 mg) (2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-10-propyl-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoacetic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A00410 | Active | Budesonide Sulfate Triethylamine Salt (10 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A04510 | Active | Canagliflozin Tetraacetate (25 mg) ((2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A00890 | Active | Carvedilol Bisalkylpyrocatechol derivative (25 mg) (3,3'-{2,2'-[1,2-Phenylenebis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A00910 | Active | Celecoxib Open Ring (25 mg) (4-((1,1,1-trifluoro-4-hydroxy-4-(p-tolyl)but-3-en-2-ylidene)amino)benzenesulfonamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A01450 | Active | Chloro N-methylthiophene Carboxamide (25 mg) (5-chloro-N-methylthiophene-2-carboxamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A02430 | Active | Chlorobutoxyquinolinone (25 mg) (7-(4-chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01560 | Active | Chlorothiophene Aldehyde (25 mg) (5-chlorothiophene-2-carbaldehyde) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01180 | Active | Chlorothiophene carboxylic acid (25 mg) (5-chlorothiophene-2-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A02710 | Active | Cisatracurium Besylate cis-Quaternary Acid (COLD SHIPMENT REQUIRED) (25 mg) ((1R,2R)-2-(2-carboxyethyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-iumbenzenesulfonate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Muscle Relaxants | Enquire
|
| 1A03630 | Active | Clarithromycin E-Oxime (COLD SHIPMENT REQUIRED) (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A03410 | Active | Clarithromycin Furanyl Analog (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A03420 | Active | Clarithromycin Z-Oxime (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00321 | Active | Clindamycin 3-Phosphate (COLD SHIPMENT REQUIRED) (10 mg) (Methyl 7-chloro-6,7,8-trideoxy-6-[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido]-1-thio-L-threo-alpha-D-galacto-octopyranoside 3-phosphate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A02100 | Active | Clopidogrel Acid N-Oxide (25 mg) (5-((S)-carboxy(2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01860 | Active | Clopidogrel Amide (25 mg) ((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A00420 | Active | Clopidogrel Diester Analog (10 mg) (R)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A02120 | Active | Clopidogrel Diester Enantiomer Sulfate (25 mg) ((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl (R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01730 | Active | Clopidogrel Ethyl Ester Sulfate (25 mg) (ethyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01890 | Active | Clopidogrel N-Oxide (25 mg) (5-((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01700 | Active | Clopidogrel Open Ring Hydrochloride (25 mg) (methyl (S)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A00430 | Active | Clopidogrel Open Ring Methyl Ester Hydrochloride (10 mg) (methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01900 | Active | Clopidogrel Open Ring R-enantiomer (25 mg) (methyl (R)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01430 | Active | Clopidogrel Piperidinylidene Analog (25 mg) ((E)-2-(1-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4-((2-(3-methoxyphenyl)-2-oxoethyl)thio)piperidin-3-ylidene)acetic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01380 | Active | Clopidogrel Quaternary Salt (25 mg) (5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-6,7-dihydrothieno[3,2-c]pyridin-5-ium, bromide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01870 | Active | Clopidogrel R-Enantiomer (25 mg) ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A02080 | Active | Clopidogrel Thienopyridinium Chloride (25 mg) (5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)thieno[3,2-c]pyridin-5-ium, chloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01360 | Active | Clopidogrel-Beta-D-glucuronide (10 mg) ((2S,3S,4S,5R,6S)-6-((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03270 | Active | Cyanocobalamin 7Beta,8Beta-lactone (25 mg) (Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-CoBeta-cyano-8Beta-hydroxycobamic a,b,d,e,g-pentaamide c,8-gamma-lactone) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Dermatology | Enquire
|
| 1A03500 | Active | Cyclopropyldiaminopurine (25 mg) (N6-cyclopropyl-9H-purine-2,6-diamine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A04270 | Active | Cyclosporin D (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Ophthamology | Enquire
|
| 1A04280 | Active | Cyclosporin H (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Ophthamology | Enquire
|
| 1A03870 | Active | D-Epinephrine (25 mg) ((S)-4-[1-Hydroxy-2-(methylamino)ethyl]pyrocatechol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03730 | Active | Dabigatran Etexilate Acid (25 mg) (3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A03740 | Active | Dabigatran Etexilate Isopropyl Ester (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A03750 | Active | Dabigatran Heptane-2-yl Analog (25 mg) (ethyl 3-(2-(((4-(N-((heptan-2-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A00160 | Active | Decarboxy Levofloxacin (25 mg) (S)-9-fluoro-3-methyl-7-oxo-10-(4-methylpiperazine-1-yl)-2,3-dihydro-7H-pyrido [1,2,3-de] -1,4-benzoxazine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00990 | Active | Decarboxy Moxifloxacin (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline) (COLD SHIPMENT REQUIRED) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A03640 | Active | Decladinosyl Clarithromycin (25 mg) (3-O-De(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)-6-O-methylerythromycin; 3-O-Decladinosyl-6-O-methylerythromycin A) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A01110 | Active | Dehydro Desloratadine (25 mg) (8-chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihistamines | Enquire
|
| 1A02980 | Active | Dehydro Ivabradine (25 mg) ((S)-3-(3-(((3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-1,3-dihydro-2H-benzo[d]azepin-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A04710 | Active | Deoxy Salmeterol (25 mg) (4-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-methylphenol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A01210 | Active | Deoxyprednisolone-16-ene Acetate (25 mg) (2-((8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01100 | Active | Deoxystreptamine Kanosaminide (25 mg) (6-O-(3-Amino-3-deoxy-alpha-D-glucopyranosyl)-2-deoxy-D-streptamine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00920 | Active | Desaryl Celecoxib (25 mg) (5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazole) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A05820 | Active | Deschlorosorafenib (25 mg) (N-Methyl-4-[4-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxamide; N-Methyl-4-{4-[3-(3-trifluoromethylphenyl)ureido]phenoxy}picolinamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A05020 | Active | Desdiethylamino Sunitinib | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A05060 | Active | Desethyl Sunitinib (25 mg) ((Z)-N-(2-(ethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A01080 | Active | Desethylamiodarone (25 mg) (2-Butyl-3-benzofuranyl-4-[2-(ethylamino)ethoxy]-3,5-diiodophenyl Ketone Hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A05700 | Active | Desethylazilsartan Nitrile Methyl Ester (25 mg) (Methyl 3-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A05600 | Active | Desethylazilsartan Open Ring | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03040 | Active | Desfluoro (3S,4R)-Paroxol (25 mg) (((3S,4R)-1-methyl-4-phenylpiperidin-3-yl)methanol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01740 | Active | Desfluorociprofloxacin Hydrochloride (25 mg) (1-cyclopropyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A01750 | Active | Desfluorocitalopram Oxalate (25 mg) (1-(3-(dimethylamino)propyl)-1-phenyl-1,3-dihydroisobenzofuran-5-carbonitrile, oxalate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A04530 | Active | Desfuranyl Empagliflozin (25 mg) ((1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-hydroxyphenyl)methyl]phenyl]-D-glucitol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A05030 | Active | Desimidazoline Sunitinib (25 mg) (5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A00720 | Active | Desiodoamiodarone (25 mg) ((2-butylbenzofuran-3-yl)(4-(2-(diethylamino)ethoxy)phenyl)methanone) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A02130 | Active | Desloratadine N-oxide (25 mg) (8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine 1-Oxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihistamines | Enquire
|
| 1A00060 | Active | Desmethoxy Omeprazole (25 mg) (2-(((3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-5-methoxy-1H-benzo[d]imidazole; 2-[(RS)-[(3,5-Dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Gastrointestinal | Enquire
|
| 1A03460 | Active | Desmethyl Bosentan (25 mg) (4-(tert-butyl)-N-(6-(2-hydroxyethoxy)-5-(2-hydroxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A07140 | Active | Desmethyl Fenofibrate | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A02810 | Active | Desmethyl Promethazine Hydrochloride (25 mg) (N-methyl-1-(10H-phenothiazin-10-yl)propan-2-amine, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihistamines | Enquire
|
| 1A01420 | Active | Desonide 21-Acetate (2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-Hydroxy-6a,8a,10,10-tetramethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A00220 | Active | Desoximetasone Acid (25 mg) (COLD SHIPMENT) ((11Beta,16alpha,17Beta)-9-Fluoro-11-hydroxy-16-methyl-3-oxoandrosta-1,4- diene-17-carboxylic acid; 9-Fluoro-11Beta-hydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17Beta-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A05650 | Active | Despropyl Macitentan (COLD SHIPMENT REQUIRED) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01480 | Active | Desthiophenerivaroxaban Methylcarbamate Analog (25 mg) (methyl ((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)carbamate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01500 | Active | Desthiophenerivaroxaban Phthalimodo Analog (25 mg) ((R)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A05420 | Active | Deutero N-Nitrosodibutylamine (NDBA-d18 ) Solution (1 mL (1 mg/mL) (N,N-Bis(butyl-d9)nitrous amide)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A05410 | Active | Deutero N-Nitrosodiethylamine (NDEA-d10) Solution (1 mL (1 mg/mL) (N,N-Bis(ethyl-d5)nitrous amide)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A00340 | Active | Dexamethasone Ethyl Ester (25 mg) (COLD SHIPMENT REQUIRED) (Ethyl 11Beta,17alpha-dihydroxy-9-fluoro-16alpha-methylandrostane-1,4-diene-3-one-17-ylcarboxylate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A00300 | Active | Dexamethasone Formate (25 mg) (COLD SHIPMENT REQUIRED) ((8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-17-(formyloxy)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A00770 | Active | Diamino Atorvastatin Calcium (25 mg) (Calcium (3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoyl]amino]-3,5-dihydroxyheptanoate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A03260 | Active | Dibenzazepinodione (50 mg) (5H-dibenzo[b,f]azepine-10,11-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02260 | Active | Dichlorothienoic Acid (25 mg) (4,5-dichlorothiophene-2-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01580 | Active | Dichlorothiophene Carboxylic Acid (25 mg) (3,5-dichlorothiophene-2-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A06200 | Active | Didesmethyl Desvenlafaxine | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02400 | Active | Diisobutyl Diazecinedione (25 mg) (4,9-Diisobutyl-1,6-diazecane-2,7-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01950 | Active | Dimethylacrylamide tolyl ketone (25 mg) ((2E)-N,N-dimethyl-4-(4-methylphenyl)-4-oxobut-2-enamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01320 | Active | Dimethylethylamine Hydrochloride (25 mg) (N,N-dimethylethanamine, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A02770 | Active | Dimethylketoprofen (COLD SHIPMENT REQUIRED) (25 mg) ((2RS)-2-[3-(2,4-Dimethylbenzoyl)phenyl]propanoic Acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A05520 | Active | Dinaphthyl Thiocarbonate | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antimicrobials | Enquire
|
| 1A01600 | Active | Diphthalimido Morpholinone Analog (25 mg) (2,2'-((2R,2'R)-((4-(3-oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A04550 | Active | Diquinolinone Butanediol (25 mg) (7,7'-(Butane-1,4-diylbis(oxy))bis(quinolin-2(1H)-one)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03720 | Active | Dithienyl glycolic acid | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A05110 | Active | Dithienyl ketone (25 mg) (Di-2-thienylmethanone) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A00250 | Active | Donepezil Quaternary Salt (Donepezilbenzyl Bromide) (25 mg) (1,1-dibenzyl-4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-ium, bromide; 1,1-dibenzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidinium, bromide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00940 | Active | Duloxetine 4-Naphthyl Isomer Hydrobromide (25 mg) (4-(3-(methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol, hydrobromide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00960 | Active | Duloxetine Alcohol (25 mg) ((R)-3-(methylamino)-1-(thiophen-2-yl)propan-1-ol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02170 | Active | Duloxetine Phenylcarbamate (50 mg) (phenyl (S)-methyl(3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)carbamate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02190 | Active | Duloxetine Phthalamide (25 mg) ((S)-2-(methyl(3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)carbamoyl)benzoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02200 | Active | Duloxetine Regioisomer (25 mg) (2-(2-(3-(methylamino)propyl)thiophen-3-yl)naphthalen-1-ol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00950 | Active | Duloxetine beta-Naphthol-1-yl Isomer (50 mg) (2-(3-(Methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02690 | Active | E-Cefepime (25 mg) (1-({(6R,7R)-7-[(E)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl}methyl)-1-methylpyrrolidinium chloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A05680 | Active | Eltrombopag Amide (25 mg) ((Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A05750 | Active | Eltrombopag Methyl Ester (25 mg) (methyl (Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A04610 | Active | Emtricitabine 2-Epimer (25 mg) (4-amino-5-fluoro-1-((2S,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one; 5-Fluoro-1-[(2S,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A04980 | Active | Emtricitabine Carboxylic Acid (25 mg) ((2R,5S)-5-(4-Amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A04620 | Active | Emtricitabine Enantiomer (25 mg) (4-amino-5-fluoro-1-((2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one; 5-Fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A05090 | Active | Emtricitabine Sulfoxide (25 mg) (4-Amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A02740 | Active | Epinephrine Hydrochloride Methoxy Analog (25 mg) (4-(1-methoxy-2-(methylamino)ethyl)benzene-1,2-diol, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A05850 | Active | Epinine Hydroiodide | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A07090 | Active | Epoxy Mometasone Furoate | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A05860 | Active | Erythromycin Oxime (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A01780 | Active | Escitalopram Acid Analog (25 mg) (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01760 | Active | Escitalopram Open Ring (25 mg) (4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A05710 | Active | Ethyl 3-amino-2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)benzoate (25 mg) (ethyl 3-amino-2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)benzoate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A07370 | Active | Ethyl Fenofibrate | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A06000 | Active | Ethyl [4-chloro-3-(trifluoromethyl)phenyl]carbamate | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A00360 | Active | Ethylpyrazinediethanol (10 mg) (2,2'-(3-ethylpyrazine-2,5-diyl)bis(ethan-1-ol)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A06440 | Active | Exemestane 6alpha-epoxide | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A06450 | Active | Exemestane 6beta-epoxide | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A07200 | Active | Fenofibrate Ether | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A00980 | Active | Fexofenadine Chloro Analog (25 mg) (COLD SHIPMENT REQUIRED) (Methyl 4-(4-Chloro-1-oxobutyl)-alpha,alpha-dimethylphenylacetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihistamines | Enquire
|
| 1A01920 | Active | Fexofenadine N-oxide (25 mg) (1-(4-(4-(2-carboxypropan-2-yl)phenyl)-4-hydroxybutyl)-4-(hydroxydiphenylmethyl)piperidine 1-oxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihistamines | Enquire
|
| 1A00731 | Active | Fexofenadine Olefin (25 mg) (2-(4-(4-(4-(diphenylmethylene)piperidin-1-yl)-1-hydroxybutyl)phenyl)-2-methylpropanoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihistamines | Enquire
|
| 1A03570 | Active | Fingolimod decyl homolog (25 mg) (2-amino-2-(4-decylphenethyl)propane-1,3-diol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Immunosuppresants | Enquire
|
| 1A03550 | Active | Fingolimod heptyl homolog (25 mg) (2-amino-2-(4-heptylphenethyl)propane-1,3-diol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Immunosuppresants | Enquire
|
| 1A03560 | Active | Fingolimod hexyl homolog (25 mg) (2-amino-2-(4-hexylphenethyl)propane-1,3-diol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Immunosuppresants | Enquire
|
| 1A03540 | Active | Fingolimod nonyl homolog (25 mg) (2-amino-2-(4-nonylphenethyl)propane-1,3-diol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Immunosuppresants | Enquire
|
| 1A01000 | Active | Floxacin Amine (25 mg) (7-amino-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00120 | Active | Fluoroandrostadiene Carboxylic Acid (25 mg) ((8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A05590 | Active | Fluticasone Acetate (25 mg) ((6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(((fluoromethyl) thio)carbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A04650 | Active | Fluticasone Furoate 17-Carboxylic Acid (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A04660 | Active | Fluticasone Oxathiolane (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A00700 | Active | Fluticasone Propionate Acid (25 mg) ((6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15, 16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A04630 | Active | Fluticasone Propionate Thioacid (25 mg) ((6alpha,11Beta,16alpha,17alpha)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01130 | Active | Fluticasone Propionate Trisulfide (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01120 | Active | Fluticasone sulfenic acid (25 mg) ((6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carbo(thioperoxoic )O-acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A03670 | Active | Fulvestrant sulfone (25 mg) ((7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfonyl)nonyl)7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A02890 | Active | Guanylmelamine Dinitrate (25 mg) (1-(4,6-diamino-1,3,5-triazin-2-yl)guanidine, nitrate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A06040 | Active | Hordenine (25 mg) (4-(2-(dimethylamino)ethyl)phenol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03110 | Active | Hydroxy Ivabradine (25 mg) (3-(3-hydroxypropyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A04930 | Active | Hydroxybenzoyl Paliperidone (25 mg) (3-(2-(4-(4-fluoro-2-hydroxybenzoyl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00310 | Active | Hydroxyisobutyl Acetophenone (25 mg) (COLD SHIPMENT REQUIRED) (1-(4-(1-hydroxy-2-methylpropyl)phenyl)ethan-1-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A00040 | Active | Hydroxythiadiazol Sulfoxide Derivative (25 mg) (4-morpholino-1,2,5-thiadiazol-3(2H)-one 1-oxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A00480 | Active | Ibuprofen Tetraethylene Glycol Diester (25 mg) (((oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl) bis(2-(4-isobutylphenyl)propanoate))) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A01910 | Active | Iodofluticasone Propionate (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01840 | Active | Isobutylglutarmonoamide (25 mg) (3-(2-Amino-2-oxoethyl)-5-methylhexanoic Acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01830 | Active | Isobutylglutarmonoamide (R-isomer) (25 mg) ((R)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03320 | Active | Isocyclosporin A (COLD SHIPMENT REQUIRED) (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Ophthamology | Enquire
|
| 1A00290 | Active | Isopropyl 4-acetylbenzoate (COLD SHIPMENT REQUIRED) (25 mg) (Isopropyl 4-acetylbenzoate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A02050 | Active | Isotachysterol3 (25 mg) (COLD SHIPMENT REQUIRED) (S)-4-methyl-3-((E)-2-((1R,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)-2,3,5,6,7,7a-hexahydro-1H-inden-4-yl)vinyl)cyclohex-3-en-1-ol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A02940 | Active | Ivabradine Amine Hydrochloride (25 mg) ((S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)-N-methylmethanamine, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03160 | Active | Ivabradine Bisbenzazepine Analog (25 mg) (3,3'-(propane-1,3-diyl)bis(7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03150 | Active | Ivabradine Chloroveratryl Analog Hydrochloride (25 mg) (3-(3-((3-chloro-2-(3,4-dimethoxyphenyl)propyl)(methyl)amino)propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03090 | Active | Ivabradine N-Oxide (25 mg) (3-(7,8-dimethoxy-2-oxo-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)-N-(((S)-3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)-N-methylpropan-1-amine oxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03130 | Active | Ivabradine Open Ring (25 mg) ((S)-2-(2-(2-((3-(((3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)(methyl)amino)propyl)amino)ethyl)-4,5-dimethoxyphenyl)acetic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03120 | Active | Ivabradine R-Enantiomer Hydrochloride (25 mg) ((R)-3-(3-(((3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03140 | Active | Ivabradine Veratryl Analog Hydrochloride (25 mg) (3-(3-((2-(3,4-dimethoxyphenyl)propyl)(methyl)amino)propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A04770 | Active | Ketovarenicline Trifluoroacetate (25 mg) (rel-(6S,10R)-8-(2,2,2-trifluoroacetyl)-1,6,7,8,9,10-hexahydro-2H-6,10-methanoazepino[4,5-g]quinoxalin-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antidotes & Chelators | Enquire
|
| 1A04500 | Active | L-Glucono-delta-lactone (25 mg) ((3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A01800 | Active | Lacosamide Acrylamide Analog (25 mg) (2-Acetamido-N-benzylacrylamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02340 | Active | Lactosyl Pregabalin Pyrrolidone (25 mg) ((S)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)-4-isobutylpyrrolidin-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A05120 | Active | Lamivudine R-sulfoxide (25 mg) ((4-amino-1-[(2R,3R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one S-oxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A05130 | Active | Lamivudine Uracil Derivative (25 mg) (1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidine-2,4(1H,3H)-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A05140 | Active | Lamivudine-trans (25 mg) (4-amino-1-[(2RS,5RS)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 1-[(2RS,5RS)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A04780 | Active | Lenalidomide Open Ring (25 mg) (2-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)pentanediamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A04790 | Active | Lenalidomide Open Ring Diacid (25 mg) (2-(4-amino-1-oxoisoindolin-2-yl)pentanedioic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A03800 | Active | Lenvatinib N-Oxide (25 mg) (6-carbamoyl-4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline 1-oxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A01960 | Active | Levamlodipine (25 mg) (3-ethyl 5-methyl (S)-2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A02220 | Active | Levetiracetam Crotonamide (10 mg) ((Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A05810 | Active | Levetiracetam acid (COLD SHIPMENT REQUIRED) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A05690 | Active | Macitentan Amine (25 mg) (5-(4-bromophenyl)-6-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)pyrimidin-4-amine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A05660 | Active | Macitentan Sulfamide Dimer (COLD SHIPMENT REQUIRED) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A02390 | Active | Mannityl Amlodipine (25 mg) (3-Ethyl 5-methyl 4-(2-chlorophenyl)-6-methyl-2-((2-(((2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)methyl)-1,4-dihydropyridine-3,5-dicarboxylate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03600 | Active | Mebetide (25 mg) (3-methyl-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Others-Chemical Medicines | Enquire
|
| 1A00710 | Active | Methoxyamiodarone (25 mg) ([2-[(1RS)-1-Methoxybutyl]benzofuran-3-yl][4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01940 | Active | Methoxycyclohexanol methacrylic aldehyde (25 mg) ((E)-3-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-2-methylacrylaldehyde) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Immunosuppresants | Enquire
|
| 1A01710 | Active | Methyl 2-chloro-Beta-D-phenylalanine (25 mg) (methyl (R)-2-amino-2-(2-chlorophenyl)acetate, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A05100 | Active | Methyl Dithienyl glycolate (25 mg) (Methyl 2-hydroxy-2,2-di(thiophen-2-yl)acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A07360 | Active | Methyl Fenofibrate | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A03350 | Active | Methyl Varenicline (25 mg) (rel-(6S,10R)-2-methyl-7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Ophthamology | Enquire
|
| 1A00930 | Active | Methyl p-Toluate (25 mg) (Methyl 4-methylbenzoate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A01490 | Active | Methylisoindolinedione (25 mg) (2-methylisoindoline-1,3-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A05010 | Active | Mirabegron N-Thiazolacetyl Analog (25 mg) ((R)-2-(2-aminothiazol-4-yl)-N-(4-(2-(2-aminothiazol-4-yl)acetamido)phenethyl)-N-(2-hydroxy-2-phenylethyl)acetamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Renal | Enquire
|
| 1A05000 | Active | Mirabegron S-Enantiomer (25 mg) ((S)-2-(2-aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Renal | Enquire
|
| 1A03250 | Active | Monochlorotriiodothyronine (25 mg) ((S)-2-Amino-3-[3-chloro-4-(4-hydroxy-3,5-diiodophenoxy)-5-iodophenyl]propanoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A01090 | Active | Monoiodoamiodarone (50 mg) ((2-Butylbenzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3-iodophenyl}methanone) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A04830 | Active | N-(2-Methoxypyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine (25 mg) (N-(2-methoxypyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A01670 | Active | N-Acetyl Desloratadine (25 mg) (1-[4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl]ethanone) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihistamines | Enquire
|
| 1A03660 | Active | N-Acetyl Lenalidomide (25 mg) (N-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)acetamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A04870 | Active | N-Acetyl Linagliptin (25 mg) ((R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A02500 | Active | N-Alkyl Aripiprazole (25 mg) (7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-1-(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butyl)-3,4-dihydroquinolin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A04600 | Active | N-Alkyl Brexpiprazole (25 mg) (7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-((2-oxo- 1,2- dihydroquinolin-7-yl)oxy)butyl)quinolin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01810 | Active | N-Benzylacetamide (25 mg) (N-Acetylbenzylamine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02960 | Active | N-Desmethyl Ivabradine Hydrochloride (25 mg) (3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]amino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A05870 | Active | N-Desmethylclarithromycin Oxime | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00180 | Active | N-Ethyl Quetiapine (25 mg) (11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03390 | Active | N-Formyl Lenalidomide (25 mg) (N-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindoIin-4-yl)formamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A04740 | Active | N-Formyl Palbociclib (25 mg) (4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carbaldehyde) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A01660 | Active | N-Hydroxy Desloratadine (25 mg) (4-(8-Chloro-5,6-dihydro-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-piperidin-1-ol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihistamines | Enquire
|
| 1A00230 | Active | N-Isopropyl Carvedilol (25 mg) (1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl](1-methylethyl)amino]-2-propanol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A02210 | Active | N-Methyl Duloxetine 3-Isomer Oxalate (25 mg) ((R)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine, oxalate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00970 | Active | N-Methyl Duloxetine Oxalate (25 mg) ((S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine, oxalate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01790 | Active | N-Methyl Lacosamide (25 mg) ((R)-2-(N-methylacetamido)-N-benzyl-3-methoxypropanamide; (R)-N-Benzyl-3-methoxy-2-(N-methylacetamido)propanamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03620 | Active | N-Methyl Lenalidomide (25 mg) (3-(4-(methylamino)-1-oxoisoindolin-2-yl)piperidine-2,6-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A03360 | Active | N-Methyl Varenicline (25 mg) (7,8,9,10-tetrahydro-8-methyl-6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Ophthamology | Enquire
|
| 1A02310 | Active | N-Methyl rac-Lacosamide (25 mg) (2-acetamido-N-benzyl-3-methoxy-N-methylpropanamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A04220 | Active | N-Nitroso Atenolol Solution (1 mL (1 mg/mL)) (2-(4-(2-hydroxy-3-(isopropyl(nitroso)amino)propoxy)phenyl)acetamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04250 | Active | N-Nitroso Bisoprolol Solution (1 mL (1 mg/mL)) (N-(2-Hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl)-N-isopropylnitrous amide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04210 | Active | N-Nitroso Carvedilol Solution (1 mL (1 mg/mL)) (N-(3-((9H-carbazol-4-yl)oxy)-2-hydroxypropyl)-N-(2-(2-methoxyphenoxy)ethyl)nitrous amide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04380 | Active | N-Nitroso Dabigatran Etexilate (10 mg) (ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04040 | Active | N-Nitroso Dabigatran Etexilate Solution (1 mL (1 mg/mL)) (ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04000 | Active | N-Nitroso Duloxetine Solution (1 mL (1 mg/mL)) (N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)-N-nitrosopropan-1-amine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04240 | Active | N-Nitroso Labetalol Solution (1 mL (1 mg/mL)) (2-hydroxy-5-(1-hydroxy-2-(nitroso(4-phenylbutan-2-yl)amino)ethyl) benzamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04200 | Active | N-Nitroso Metoprolol Solution (1 mL (1 mg/mL)) (N-(2-hydroxy-3-(4-(2-methoxyethyl)phenoxy)propyl)-N-isopropylnitrous amide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A03980 | Active | N-Nitroso Nortriptyline Solution (1 mL (1 mg/mL)) (N-(3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl)-N-methylnitrous amide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04230 | Active | N-Nitroso Propranolol Solution (1 mL (1 mg/mL)) (1-[(1-Methylethyl)nitrosoamino]-3-(1-naphthalenyloxy)-2-propanol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04450 | Active | N-Nitroso Quinapril (10 mg) ((S)-2-(N-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-N-nitroso-L-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04180 | Active | N-Nitroso Quinapril Solution (1 mL (1 mg/mL)) ((S)-2-(N-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-N-nitroso-L-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04030 | Active | N-Nitroso Rasagiline Solution (1 mL (1 mg/mL)) ((R)-N-(2,3-Dihydro-1H-inden-1-yl)-N-(prop-2-yn-1-yl)nitrous amide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04360 | Active | N-Nitroso Sitagliptin Amine (NTTP) (10 mg) (7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A03960 | Active | N-Nitroso Sitagliptin Amine (NTTP) Solution (1 mL (1 mg/mL) (7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04390 | Active | N-Nitroso Tamsulosin (10 mg) ((R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)(nitroso)amino)propyl)-2-methoxybenzenesulfonamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04050 | Active | N-Nitroso Tamsulosin Solution (1 mL (1 mg/mL)) ((R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)(nitroso)amino)propyl)-2-methoxybenzenesulfonamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04090 | Active | N-Nitroso Tetraxetan Triacetic Acid (10 mg) (2,2',2''-(10-nitroso-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04350 | Active | N-Nitroso Varenicline (NNV) (10 mg) (8-nitroso-7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A03920 | Active | N-Nitroso Varenicline (NNV) Solution (1mL (1 mg/mL)) (8-nitroso-7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A03970 | Active | N-Nitroso-1,2,3,6-tetrahydropyridine (NTHP) Solution (1 mL (1 mg/mL)) (1-nitroso-1,2,3,6-tetrahydropyridine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A03990 | Active | N-Nitroso-N-methyl-2-phenylethylamine (NMPEA) Solution (1 mL (1 mg/mL)) (N-methyl-N-phenethylnitrous amide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A05290 | Active | N-Nitrosodiethanolamine (NDELA) Solution (1 mL (1 mg/mL)) (N,N-Bis(2-hydroxyethyl)nitrosoamine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A05190 | Active | N-Nitrosodiphenylamine (NDPh) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A05180 | Active | N-Nitrosodiphenylamine (NDPh) Solution (1 mL (1 mg/mL)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A03930 | Active | N-Nitrosodipropylamine (NDPA) Solution (1 mL (1 mg/mL)) (N,N-dipropylnitrous amide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04400 | Active | N-Nitrosoiminodiacetic acid (10 mg) (2,2'-(nitrosoazanediyl)diacetic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04070 | Active | N-Nitrosoiminodiacetic acid Solution (1 mL (1 mg/mL)) (2,2'-(nitrosoazanediyl)diacetic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A03940 | Active | N-Nitrosomethylphenidate (NMPH) Solution (1 mL (1 mg/mL)) (Methyl 2-(1-nitrosopiperidin-2-yl)-2-phenylacetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A03950 | Active | N-Nitrosopiperidine Solution (1 mL (1 mg/mL)) (1-Nitrosopiperidine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A04060 | Active | N-Nitrosopyrrolidine (NPYR) Solution (1 mL (1 mg/mL) (1-Nitrosopyrrolidine)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Nitrosamines | Enquire
|
| 1A03010 | Active | N-Phenoxycarbonyl Paroxetine (25 mg) (phenyl (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02580 | Active | N1-(2-Chloroethyl)-N2-(2,3-dichlorophenyl)ethane-1,2-diamine hydrochloride (25 mg) (N1-(2-chloroethyl)-N2-(2,3-dichlorophenyl)ethane-1,2-diamine, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00530 | Active | N6-(1-Iminoethyl)-D-lysine (10 mg) ((2R)-2-[(2S)-2-Aminobutanamido]butanamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00390 | Active | Nebramine (10 mg) ((1S,2R,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)cyclohexane-1,2-diol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A05640 | Active | Nintedanib Acid | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A01590 | Active | Nitrophenylchlorothiophene Carboxylate (25 mg) (4-nitrophenyl 5-chlorothiophene-2-carboxylate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A03680 | Active | Nonylene bisestradiol (25 mg) (8R,8'R,9S,9'S,13S,13'S,14S,14'S,17S,17'S)-7,7'-(nonane-1,9-diyl)bis(13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A04940 | Active | Norbornanedicarboximide (25 mg) (rel-(3aR,4S,7R,7aS)-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03470 | Active | O-Acetyl Bosentan (25 mg) (2-((6-((4-(tert-butyl)phenyl)sulfonamido)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)oxy)ethyl acetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A04470 | Active | O-Desmethyl Apremilast (25 mg) ((S)-N-(2-(1-(3-ethoxy-4-hydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Immunosuppresants | Enquire
|
| 1A03310 | Active | O-Desmethylmetoprolol (25 mg) (1-(4-(2-hydroxyethyl)phenoxy)-3-(isopropylamino)propan-2-ol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A06410 | Active | O-Thienylethyl Rotigotine Hydrochloride | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01010 | Active | Olanzapine lactam (25 mg) ((Z)-4-(4-methylpiperazin-1-yl)-3-(2-oxopropylidene)-1,3-dihydro-2H-benzo[b][1,4]diazepin-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01020 | Active | Olanzapine thiolactam (25 mg) ((Z)-1-(4-(4-Methylpiperazin-1-yl)-2-thioxo-1,2-dihydro-3H-benzo[b][1,4]diazepin-3-ylidene)propan-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01720 | Active | Open Ring N-Methyl Clopidogrel Hydrochloride (25 mg) (methyl (S)-2-(2-chlorophenyl)-2-(methyl(2-(thiophen-2-yl)ethyl)amino)acetate, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A03330 | Active | Orlistat Open Ring Amide (25 mg) (N-Formyl-L-leucine(S)-1-[(2S,3S)-2-hydroxy-3-[1-phenyl-R-ethyl-carbomoyl]nonyl]-dodecyl ester) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A03000 | Active | Paroxetine Hydrochloride Catechol Analog (25 mg) (4-(((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methoxy)benzene-1,2-diol, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02990 | Active | Paroxetine Hydrochloride Piperidinemethanol Analog (25 mg) (((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methanol, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03050 | Active | Paroxetine Methoxy (3R,4S)-Enantiomer Hydrochloride (25 mg) ((3R,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03060 | Active | Paroxol (25 mg) ((4R,3S)-4-(4-Fluorophenyl)-1-methyl-3-piperidinemethanol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01140 | Active | Pemetrexed Acid (25 mg) (4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A00630 | Active | Pemetrexed Acid N-Hydroxysuccinimide Ester (25 mg) (2,5-dioxopyrrolidin-1-yl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A00640 | Active | Pemetrexed Dimethyl Ester (25 mg) (dimethyl (4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-L-glutamate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A00620 | Active | Pemetrexed Disodium Enantiomer (25 mg) ((2R)-2-[[4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid, sodium salt) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A01150 | Active | Pemetrexed Glutamide Sodium (25 mg) ((S)-4-((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-4-carboxybutanamido)-4-carboxybutanoate, sodium salt) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A00610 | Active | Pemetrexed Glutamide Trisodium Salt (25 mg) (((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-4-carboxybutanoyl)-L-glutamic acid, sodium salt) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A02360 | Active | Pemetrexed Sodium 1-Methyl Ester (25 mg) ((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-5-methoxy-5-oxopentanoic acid, sodium salt) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A02370 | Active | Pemetrexed Sodium 5-Methyl Ester (25 mg) ((S)-2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-5-methoxy-5-oxopentanoic acid, sodium salt) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A02230 | Active | Pemetrexed Tromethamide (25 mg) (N2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-N5-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-L-glutamine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A04690 | Active | Phenylethoxy Salmeterol (25 mg) (4-(1-hydroxy-2-((6-phenethoxyhexyl)amino)ethyl)-2-(hydroxymethyl)phenol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A04700 | Active | Phenylpropoxy Salmeterol (25 mg) (4-(1-hydroxy-2-((6-(3-phenylpropoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol; 4-{1-Hydroxy-2-[6-(3-phenylpropoxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A06290 | Active | Piperacillin Sulfoxide | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A03070 | Active | Piperazinedionecarbonyl D-phenylglycylglycine (25 mg) ((R)-(2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetyl) glycine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A02320 | Active | Pregabalin Diethylamide D-Tartrate (25 mg) ((S)-3-(Aminomethyl)-N,N-diethyl-5-methylhexanamide (2S,3S)-2,3-dihydroxysuccinate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00450 | Active | Pyrazinediethanol (10 mg) (2,2'-(pyrazine-2,5-diyl)bis(ethan-1-ol)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00380 | Active | Pyrazinediethanol Propionic Acid (5 mg) (3-(3,6-bis(2-hydroxyethyl)pyrazin-2-yl)propanoate, sodium salt) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00460 | Active | Pyrrolic acid Derivative (10 mg) (4-(2-hydroxyethyl)-1H-pyrrole-3-carboxylic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00190 | Active | Quetiapine Desethoxy (COLD SHIPMENT REQUIRED)(25 mg) (2-[4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethanol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00130 | Active | Quetiapine Tetraethylene Glycol Fumarate Salt (COLD SHIPMENT REQUIRED) (2-(2-(2-(2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethan-1-ol-fumarate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00140 | Active | R,R,S-Ezetimibe (25 mg) ((3R,4S)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A03610 | Active | R,R-Lamivudine (25 mg) (4-amino-1-((2R,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A00370 | Active | R-Levetiracetam Hydroxybutyramide Analog (10 mg) ((R)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A04760 | Active | Rac-Trans-4-Hydroxy Tolvaptan (10 mg) (rel-N-(4-((4S,5S)-7-chloro-4,5-dihydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Renal | Enquire
|
| 1A03810 | Active | Rifamycin O (25 mg) (4-O-(Carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-rifamycin gamma-Lactone) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A00600 | Active | Risperidone Difluoroketone (10 mg) (3-(2-(4-(2,4-difluorobenzoyl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01160 | Active | Rivaroxaban Amine (25 mg) ((S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01470 | Active | Rivaroxaban Desmorpholinone Analog (25 mg) ((S)-5-chloro-N-((3-(4-((2-hydroxyethyl)amino)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01510 | Active | Rivaroxaban Desthiophene Analog (25 mg) ((R)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A02250 | Active | Rivaroxaban Ethyl Carbamate (25 mg) (ethyl (4-(3-oxomorpholino)phenyl)carbamate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A02300 | Active | Rivaroxaban Ethylamino Analog (25 mg) (1-amino-3-((4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01170 | Active | Rivaroxaban Glycolic Acid Analog (25 mg) ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01190 | Active | Rivaroxaban N-acyl glycolic acid (25 mg) ((S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01520 | Active | Rivaroxaban N-methylphthalamido Analog (25 mg) ((S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01460 | Active | Rivaroxaban Open Chain Dithiophene Analog (10 mg) ((S)-5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-(methylamino)-2-oxoethoxy)ethyl)thiophene-2-carboxamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A02240 | Active | Rivaroxaban Open Oxomorpholine Ring (10 mg) ((S)-5-chloro-N-((3-(4-(2-hydroxy-N-(2-hydroxyethyl)acetamido) phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A00670 | Active | Rivaroxaban Open Ring (10 mg) ((R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A00650 | Active | Rivaroxaban Open Ring Methylamine (10 mg) ((S)-4-(4-((2-hydroxy-3-(methylamino)propyl)amino)phenyl)morpholin-3-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01550 | Active | Rivaroxaban Open Ring S-isomer (25 mg) ((S)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A00660 | Active | Rivaroxaban Phthalamide (25 mg) (N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A02270 | Active | Rivaroxaban Phthalimide (25 mg) ((S)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01570 | Active | Rivaroxaban Phthalimido Analog (25 mg) ((R)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A02280 | Active | Rivaroxaban isomer (25 mg) (4-(4-(((2-(5-chlorothiophen-2-yl)-4,5-dihydrooxazol-5-yl)methyl)amino)phenyl)morpholin-3-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A02290 | Active | Rivaroxaban phthalimido ethyl ester analog (25 mg) ((S)-1-(1,3-dioxoisoindolin-2-yl)-3-((ethoxycarbonyl)(4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A00170 | Active | Rosuvastatin Isoamyl Ester (25 mg) ((3S,5R,6E)-7-[4-(4-flurophenyl)-6-(1-methylethyl)-2-[N-methyl(methylsulphonyl)amino]-5-pyrimidinyI]-3,5-dihydroxy-6-heptanoic acid, methyl butyl ester) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A00050 | Active | Rosuvastatin Ketone (25mg) ((R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A01200 | Active | Rosuvastatin Lactone (25 mg) (N-[4-(4-Fluorophenyl)-5-{(E)-2-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]vinyl}-6-isopropylpyrimidin-2-yl]-N-methylmethanesulfonamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antihyperlipidemics | Enquire
|
| 1A06400 | Active | Rotigotine Hydrochloride Ethyl Analog | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A06350 | Active | Rotigotine O-Tosylate Hydrochloride | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00440 | Active | S-Levetiracetam Hydroxybutyramide Analog (10 mg) ((S)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A04890 | Active | Scopine di(2-thienylglycolate) (25 mg) (2-Thiopheneacetic acid, alpha-hydroxy-alpha-2-thienyl-, (1alpha,2beta,4beta,5alpha,7beta)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0 2,4]non-7-yl ester) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A02620 | Active | Sitagliptin (R)-Triazecine Analog (25 mg) ((R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A02840 | Active | Sitagliptin Acid (25 mg) ((R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A02660 | Active | Sitagliptin Alcohol (25 mg) (3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A02650 | Active | Sitagliptin Enamine (25 mg) ((Z)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A02670 | Active | Sitagliptin Ketone (25 mg) (1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butane-1,3-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A02600 | Active | Sitagliptin Phenylcrotonyl Analog (25 mg) ((E)-1-{3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl}-4-(2,4,5-trifluorophenyl)but-2-en-1-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A02610 | Active | Sitagliptin Styrylacetyl Analog (25 mg) ((E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-3-en-1-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A04290 | Active | Sodium 4-Hydroxy-N-methylleucinate (25 mg) (4-hydroxy-4-methyl-2-(methylamino)pentanoic acid, sodium salt) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Ophthamology | Enquire
|
| 1A05990 | Active | Sorafenib Diarylurea Analog (25 mg) (4,4'-[carbonylbis(azanediyl-4,1-phenyleneoxy)]bis(N-methylpyridine-2-carboxamide);N,N'-Bis{4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl}urea) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A05840 | Active | Sorafenib Formamide (25 mg) (4-(4-formamidophenoxy)-N-methylpicolinamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A04310 | Active | Sugammadex Sodium Sulfone (10 mg) (6A,6B,6C,6D,6E,6F,6G,6H-octadeoxy-6A,6B,6C,6D,6E,6F,6G,6H-octaki-gamma-Cyclodextrin, sodium salt) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Others-Chemical Medicines | Enquire
|
| 1A04560 | Active | Sugammadex Sodium Sulfoxide (10 mg) (6A,6B,6C,6D,6E,6F,6G,6H-octadeoxy-6A,6B,6C,6D,6E,6F,6G,6H-octakis[(2-carboxyethyl)sulfinyl]-gamma-Cyclodextrin, sodium salt) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Others-Chemical Medicines | Enquire
|
| 1A05040 | Active | Sunitinib Amide (25 mg) (5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A05050 | Active | Sunitinib N-Oxide (25 mg) ((Z)-N,N-diethyl-2-(5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamido)ethan-1-amine oxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A01290 | Active | TEMED Dihydrochloride (25 mg) (N1,N1,N2,N2-tetramethylethane-1,2-diamine, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A01930 | Active | Tacrolimus 5E-ene (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Immunosuppresants | Enquire
|
| 1A06940 | Active | Tamsulosin Amine | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Oncology | Enquire
|
| 1A04320 | Active | Tenofovir Soproxil (((((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(hydroxy)phosphoryl)oxy)methyl isopropyl carbonate) (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antivirals | Enquire
|
| 1A01850 | Active | Tetrahydrothienopyridine Hydrochloride (25 mg) (4,5,6,7-Tetrahydrothieno[3,2-c]pyridine, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A00400 | Active | Tetramethyl Ethylene Diamine (25 mg) (N1,N1,N2,N2-tetramethylethane-1,2-diamine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A02680 | Active | Thiazolylacetyl Glycine Oxime Acetal | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A04640 | Active | Ticabesone Furoate (25 mg) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Steroids | Enquire
|
| 1A01440 | Active | Ticlopidine Pyridinium Analog (25 mg) (5-(2-chlorobenzyl)thieno[3,2-c]pyridin-5-ium, chloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01690 | Active | Ticlopidine Pyridinium Bromide Analog (25 mg) (5-(2-chlorobenzyl)-6,7-dihydrothieno[3,2-c]pyridin-5-ium, bromide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A01620 | Active | Tolterodine Dimer (25 mg) (2,2'-((isopropylazanediyl)bis(1-phenylpropane-3,1-diyl))bis(4-methylphenol); N,N-Bis[3-(2-hydroxy-5-methylphenyl)-3-phenylpropyl]-N-isopropylamine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Renal | Enquire
|
| 1A01680 | Active | Tolterodine Propanol Analog (25 mg) (2-(3-Hydroxy-1-phenylpropyl)-4-methylphenol) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Renal | Enquire
|
| 1A04730 | Active | Tolvaptan Open Ring Hydroxyacid (25 mg) (4-(5-chloro-2-(2-methyl-4-(2-methylbenzamido)benzamido)phenyl)-4-hydroxybutanoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Renal | Enquire
|
| 1A04720 | Active | Tolvaptan Open Ring Ketoacid (25 mg) (4-(5-chloro-2-(2-methyl-4-(2-methylbenzamido)benzamido)phenyl)-4-oxobutanoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Renal | Enquire
|
| 1A04750 | Active | Tolvaptan S-Enantiomer (10 mg) ((S)-N-(4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Renal | Enquire
|
| 1A00750 | Active | Tolyloyl Bromopropionamide (25 mg) (3-bromo-N,N-dimethyl-4-oxo-4-(p-tolyl)butanamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01630 | Active | Tolyloyl Propionamide (25 mg) (N,N-Dimethyl-4-oxo-4-(p-tolyl)butanamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A01640 | Active | Tolyloyl Propionic Acid (25 mg) (4-Oxo-4-(p-tolyl)butanoic Acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A05500 | Active | Trimethoprim Acrylonitrile Analog | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A01820 | Active | Ureidolacosamide (25 mg) ((R)-N-Benzyl-2-(3-benzylureido)-3-methoxypropanamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A03370 | Active | Varenicline Acetamide (25 mg) (COLD SHIPMENT REQUIRED) (1-(6,7,9,10-tetrahydro-8H-6,10-methanoazepino[4,5-g]quinoxalin-8-yl)ethan-1-one) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Ophthamology | Enquire
|
| 1A03340 | Active | Varenicline Formamide (25 mg) (6,7,9,10-tetrahydro-8H-6,10-methanoazepino[4,5-g]quinoxaline-8-carbaldehyde) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Ophthamology | Enquire
|
| 1A03820 | Active | Vilanterol Desethylene Homolog Triphenylacetate (25 mg) ((R)-4-(2-((6-((2,6-dichlorobenzyl)oxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol, 2,2,2-triphenylacetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A03910 | Active | Vilanterol Diamine Triphenylacetate (25 mg) (4,4'-((1R,1'R)-((oxybis(hexane-6,1-diyl))bis(azanediyl))bis(1-hydroxyethane-2,1-diyl))bis(2-(hydroxymethyl)phenol), 2,2,2-triphenylacetate)) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A03860 | Active | Vilanterol Trifenatate Dioxin (50 mg) ((alphaR)-alpha-[[[6-[2-[(2,6- Dichlorophenyl)methoxy] ethoxy]hexyl] amino]methyl]-2,2-dimethyl-4H-1,3-benzodioxin-6-methanol, triphenylacetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A03850 | Active | Vilanterol Trifenatate S-Enantiomer (25 mg) ((S)-4-(2-((6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol 2,2,2-triphenylacetate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A07170 | Active | Z-Montelukast | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Pulmonary | Enquire
|
| 1A04950 | Active | cis-Lurasidone Hydrochloride (25 mg) (rel-(3aR,4S,7R,7aS)-2-(((1R,2S)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione, hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A04960 | Active | endo-Lurasidone (25 mg) ((3aR,4R,7S,7aS)-2-{[1R,2R]-2-[4-(1,2-benzisothiazol-3-yl)-piperazin-1-yl-methyl]-cyclohexyl methyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A00240 | Active | o-Celecoxib (25mg) (4-(5-(o-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Analgesics | Enquire
|
| 1A02330 | Active | rac-4,5-Dehydropregabalin (25 mg) (3-(aminomethyl)-5-methylhex-4-enoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02350 | Active | rac-5,6-Dehydropregabalin (25 mg) (3-(aminomethyl)-5-methylhex-5-enoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02110 | Active | rac-Clopidogrel Acid N-Oxide (25 mg) (5-(carboxy(2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Cardiovascular | Enquire
|
| 1A02180 | Active | rac-Duloxetine-d7 Maleate (25 mg) (N-methyl-3-((naphthalen-1-yl-d7)oxy)-3-(thiophen-2-yl)propan-1-amine, maleate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02380 | Active | rac-Pregabalin Imide Dimer Amide (25 mg) (3-((3-(aminomethyl)-5-methylhexanamido)methyl)-5-methylhexanoic acid) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Psychiatrics | Enquire
|
| 1A02640 | Active | rac-Sitagliptin Hydrochloride (25 mg) (3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one hydrochloride) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
| 1A04810 | Active | tert-Butyl ((1R,2R,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamate oxalate (25 mg) (tert-butyl ((1R,2R,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamate oxalate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A04800 | Active | tert-Butyl ((1S,2R,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamate oxalate (25 mg) (tert-butyl ((1S,2R,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamate oxalate) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Anticoagulants & Antiplatelets | Enquire
|
| 1A01310 | Active | tert-Octylamine (25 mg) (2,4,4-trimethylpentan-2-amine) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Antibiotics | Enquire
|
| 1A02060 | Active | trans-Cholecalciferol (25 mg) (COLD SHIPMENT REQUIRED) | Pharmaceutical Analytical Impurity | Pharmaceutical Analytical Impurities | Endocrine | Enquire
|
